Rufen

   
Google
 
Web NewDrugInformation.com

Rufen


Drug - Rufen
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ibuprofen
Multiple ingredients are in alphabetical order.

Strength - 600MG
The potency of the active ingredient(s), Ibuprofen. May repeat for multiple part products.

Applicant - BASF
The firm name holding legal responsibility for Rufen. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 018197
The FDA assigned number to Rufen. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Rufen. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 5, 1984
The date Rufen was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Rufen. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Rufen is in. Format is RX, OTC, DISCN.

Applicant Full Name - Basf Corp
The full name of the firm holding legal responsibility for the new application of Rufen.

Rufen